FEELLIFE Nebulization Research Institute Opens the New Chapter in Inhalation Vaccine Mission – Press Release

The NGS based CDx Human NTRK1/2/3 Genomic Alteration Test Kit to inform treatment decisions for larotrectinib developed by OrigiMed in cooperation with Bayer was granted the NMPA Special Review Procedure for Innovative Medical Devices in China - Press Release